tiprankstipranks
Trending News
More News >
Krystal Biotech (KRYS)
NASDAQ:KRYS
US Market

Krystal Biotech (KRYS) Ratios

Compare
622 Followers

Krystal Biotech Ratios

KRYS's free cash flow for Q3 2025 was $0.94. For the 2025 fiscal year, KRYS's free cash flow was decreased by $ and operating cash flow was $0.49. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
10.14 7.28 17.76 13.30 17.18
Quick Ratio
9.73 7.02 17.55 13.30 17.18
Cash Ratio
4.30 3.38 10.83 5.61 13.26
Solvency Ratio
2.01 0.88 0.40 -3.75 -2.04
Operating Cash Flow Ratio
1.93 1.21 -2.68 -3.49 -1.86
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -64.43 0.00
Net Current Asset Value
$ 823.43M$ 632.59M$ 548.20M$ 347.56M$ 409.55M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.02 0.01
Debt-to-Equity Ratio
<0.01 <0.01 0.01 0.02 0.01
Debt-to-Capital Ratio
<0.01 <0.01 0.01 0.02 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.09 1.12 1.05 1.07 1.06
Debt Service Coverage Ratio
0.00 0.00 0.00 -26.43 -45.60
Interest Coverage Ratio
0.00 0.00 0.00 -27.81 -45.76
Debt to Market Cap
0.00 0.00 0.00 <0.01 0.00
Interest Debt Per Share
0.33 0.25 0.30 0.56 0.43
Net Debt to EBITDA
-2.24 -3.07 -19.56 1.05 5.10
Profitability Margins
Gross Profit Margin
93.89%93.09%93.90%0.00%0.00%
EBIT Margin
44.17%35.52%25.44%0.00%0.00%
EBITDA Margin
45.87%37.83%35.31%0.00%0.00%
Operating Profit Margin
42.40%22.61%-216.43%0.00%0.00%
Pretax Profit Margin
50.10%32.82%25.44%0.00%0.00%
Net Profit Margin
53.30%30.69%21.56%0.00%0.00%
Continuous Operations Profit Margin
53.30%30.69%21.56%0.00%0.00%
Net Income Per EBT
106.40%93.50%84.76%100.00%100.00%
EBT Per EBIT
118.14%145.15%-11.75%96.40%101.90%
Return on Assets (ROA)
16.04%8.44%1.34%-25.06%-11.11%
Return on Equity (ROE)
19.36%9.42%1.40%-26.80%-11.72%
Return on Capital Employed (ROCE)
13.77%6.89%-13.97%-27.42%-11.37%
Return on Invested Capital (ROIC)
13.75%6.43%-11.82%-33.88%-11.79%
Return on Tangible Assets
16.04%8.44%1.34%-25.06%-11.11%
Earnings Yield
2.46%1.99%0.32%-6.93%-4.48%
Efficiency Ratios
Receivables Turnover
2.88 2.77 1.21 0.00 0.00
Payables Turnover
10.88 4.02 1.67 1.02 0.33
Inventory Turnover
0.61 0.76 0.44 0.00 0.00
Fixed Asset Turnover
2.39 1.80 0.30 0.00 0.00
Asset Turnover
0.30 0.28 0.06 0.00 0.00
Working Capital Turnover Ratio
0.47 0.49 0.11 0.00 0.00
Cash Conversion Cycle
695.54 523.20 908.56 -358.34 -1.11K
Days of Sales Outstanding
126.80 131.60 302.66 0.00 0.00
Days of Inventory Outstanding
602.31 482.30 824.02 0.00 0.00
Days of Payables Outstanding
33.56 90.70 218.13 358.34 1.11K
Operating Cycle
729.11 613.90 1.13K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
6.09 4.32 -3.27 -3.95 -2.16
Free Cash Flow Per Share
5.72 4.17 -3.70 -6.02 -5.24
CapEx Per Share
0.37 0.15 0.43 2.08 3.08
Free Cash Flow to Operating Cash Flow
0.94 0.97 1.13 1.53 2.43
Dividend Paid and CapEx Coverage Ratio
16.60 29.12 -7.53 -1.90 -0.70
Capital Expenditure Coverage Ratio
16.60 29.12 -7.53 -1.90 -0.70
Operating Cash Flow Coverage Ratio
18.53 17.00 -10.97 -11.26 -5.97
Operating Cash Flow to Sales Ratio
0.47 0.42 -1.75 0.00 0.00
Free Cash Flow Yield
2.04%2.66%-2.99%-7.60%-7.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
40.65 50.24 308.15 -14.43 -22.32
Price-to-Sales (P/S) Ratio
21.70 15.42 66.45 0.00 0.00
Price-to-Book (P/B) Ratio
7.11 4.73 4.33 3.87 2.62
Price-to-Free Cash Flow (P/FCF) Ratio
48.90 37.58 -33.49 -13.15 -13.35
Price-to-Operating Cash Flow Ratio
45.88 36.29 -37.93 -20.08 -32.39
Price-to-Earnings Growth (PEG) Ratio
1.16 0.07 -2.87 -0.19 -0.27
Price-to-Fair Value
7.11 4.73 4.33 3.87 2.62
Enterprise Value Multiple
45.07 37.68 168.59 -12.85 -18.67
Enterprise Value
7.71B 4.14B 3.02B 1.87B 1.22B
EV to EBITDA
45.07 37.68 168.59 -12.85 -18.67
EV to Sales
20.67 14.26 59.54 0.00 0.00
EV to Free Cash Flow
46.59 34.75 -30.00 -12.16 -10.49
EV to Operating Cash Flow
43.78 33.56 -33.99 -18.56 -25.44
Tangible Book Value Per Share
39.30 33.10 28.67 20.49 26.74
Shareholders’ Equity Per Share
39.30 33.10 28.67 20.49 26.74
Tax and Other Ratios
Effective Tax Rate
-0.06 0.06 0.15 -0.24 -0.04
Revenue Per Share
12.89 10.16 1.87 0.00 0.00
Net Income Per Share
6.87 3.12 0.40 -5.49 -3.13
Tax Burden
1.06 0.94 0.85 1.00 1.00
Interest Burden
1.13 0.92 1.00 1.00 1.00
Research & Development to Revenue
0.15 0.18 0.92 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.11 0.17 0.79 0.00 0.00
Income Quality
0.89 1.38 -8.12 0.72 0.69
Currency in USD